Extraordinary General Meeting 2017

The shareholders in Oncopeptides AB (publ), reg. no. 556596-6438, are hereby given notice to attend an extraordinary shareholders’ meeting to be held at the company’s premises on Västra Trädgårdsgatan 15 in Stockholm, Sweden, on Monday, 6 February 2017 at 9:00 a.m. (CET).

Upcoming events

Silent Period

-

Interim Report Q2 2021

08:00 CET

Silent Period

-

Interim Report Q3 2021

08:00 CET